| Financial Year |
March 31 2023 |
| Monetary Funds |
703,506,678.80 |
| Held-for-trading Financial Assets |
290,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
377,882,991.88 |
| Advances to Suppliers |
5,295,938.43 |
| Other Receivables |
14,372,045.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
673,575,446.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,261,311.20 |
| Total Current Assets |
2,123,761,495.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
470,277,917.68 |
| Under-construction Projects |
267,935,439.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
149,151,319.89 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,266,888.60 |
| Deferred Income Tax Assets |
34,261,283.89 |
| Other Non-Current Assets |
79,123,119.08 |
| Sub-Total of Non-Current Assets |
1,109,664,293.96 |
| Total Assets |
3,233,425,789.22 |
| Short-Term Loans |
249,715,948.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
138,645,142.17 |
| Accounts Payable |
182,156,513.09 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,265,836.53 |
| Taxes Payable |
11,561,349.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,260,593.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,078,318.64 |
| Other Current Liabilities |
426,517.05 |
| Sub-Total of Current Liabilities |
610,391,120.10 |
| Long-term Loans |
60,060,000.00 |
| Bonds Payable |
525,048,048.83 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
21,107,634.22 |
| Deferred Income Tax Liabilities |
23,379,680.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
791,796,481.45 |
| Total Liabilities |
1,402,187,601.55 |
| Paid-In Capital(Or Share Stock) |
166,602,107.00 |
| Capital Surplus |
921,570,584.13 |
| Surplus Reserve |
76,145,227.08 |
| LESS:Treasury Stock |
111,570,524.34 |
| Undistributed Profits |
634,851,728.20 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,831,238,187.67 |
| Owner's Equity（Stockholder's Equity） |
1,831,238,187.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,233,425,789.22 |
